Chesapeake Energy (NASDAQ:CHK) reported quarterly earnings of $4.87 per share which beat the analyst consensus estimate of $3.81 by 27.82 percent. This is a 196.95 percent increase over earnings of $1.64 per share from the same period last year.
Rare Disease Player Cyclo Therapeutics To Merge With Applied Molecular Transport
Applied Molecular Transport Inc (NASDAQ: AMTI) has agreed to merge with Cyclo Therapeutics Inc (NASDAQ: CYTH) in an